Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas

Annals of Neurology

Volumn 46, Issue 6, 1999, Pages 913-916

  Zhou, Xiao Ping ^a   Sanson, Marc ^b,c   Hoang Xuan, Khê ^b   Robin, Eric ^b   Taillandier, Luc ^b   He, Jié ^b   Mokhtari, Karima ^c   Cornu, Philippe ^c   Delattre, Jean Yves ^b   Thomas, Gilles ^a   Hamelin, Richard ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHU NANCY BRABOIS   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16; PROTEIN P53;

ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; FAMILIAL CANCER; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENETIC PREDISPOSITION; GLIOMA; HUMAN; MISSENSE MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AMINO ACID SUBSTITUTION; ASTROCYTOMA; BRAIN NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EXONS; FAMILY; FEMALE; GENES, P16; GENES, P53; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; GLIOMA; HUMANS; MALE; NEOPLASMS; PHOSPHORIC MONOESTER HYDROLASES; POINT MUTATION; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0032707552     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199912)46:6<913::AID-ANA15>3.0.CO;2-X     Document Type: Article

References (20)

1. Ikizler Y, Van Meyel DJ, Ramsay DA, et al. Gliomas in families. Can J Neurol Sci 1992;19:492-497
2. Lossignol D, Grossman SA, Sheidler VR, et al. Familial clustering of malignant astrocytomas. J Neurooncol 1990;9:139-145
3. Knudson AG. Hereditary cancer, oncogenes and antioncogenes. Proc Natl Acad Sci USA 1993;90:10914-10921
4. Von Deimling A, Eibl RH, Ohgaki H, et al. P53 mutations are associated with allelic loss in grade 2 and 3 astrocytoma. Cancer Res 1992;52:2987-2990
5. Li YL, Hoang-Xuan K, Delattre JY. et al. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas. Oncogene 1995;11:597-600
6. Zhou XP, Li YJ, Hoang-Xuan K, et al. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Int J Cancer 1999;84:150-154
7. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-1238
8. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nat Genet 1994;8:15-21
9. Liaw D, Marsh DJ, Li J, et al. Germline mutation of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-67
10. Jensen S, Paderanga DC, Chen P, et al. Molecular analysis at the NF1 locus in astrocytic brain tumors. Cancer 1995;76: 674-677
11. Henske EP, Scheithauer BW, Short MP, et al. Allelic loss is frequent in tuberous sclerosis kydney lesions but rare in brain lesions. Am J Hum Genet 1996;59:400-406
12. Mori T, Nagase H, Horii A, et al. Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors. Genes Chromosomes Cancer 1994;9:168-172
13. Li YL, Sanson M, Hoang-Xuan K, et al. p53 mutations in patients with gliomas. Int J Cancer 1995;64:383-387
14. Kyritsis AP, Bondy ML, Xiao M, et al. Germline p53 gene mutations in a subset of glioma patients. J Natl Cancer Inst 1994;86:344-349
15. Hamelin R, Jego N, Laurent-Puig P, et al. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene 1993;8:2213-2220
16. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 1994;265:415-416
17. Wu JK, Ye Z, Darras BT. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors. Neurosurgery 1993;33:824-831
18. Van Meyel DJ, Ramsay DA, Chambers AF, et al. Absence of hereditary mutations in exons 5 through 9 of the p53 gene and exon 24 of the neurofibromin gene in families with glioma. Ann Neurol 1994;35:120-122
19. Schmidt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994;54:6321-6324
20. Marsh DJ, Coulon V, Luinetta KL, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998;7:507-515